Agilent Early Career Professor Award (AECPA)
Agilent congratulates Jason Yang
Winner of the 2021 Agilent Early Career Professor Award
2021 Focus: Contributions to the development of breakthrough solutions to understand or manage immunological responses to infection, autoimmunity or cancer.
Jason Yang, Ph.D.
Assistant Professor and Chancellor Scholar
Ruy V. Lourenço Center for Emerging and Re-Emerging Pathogens
Department of Microbiology, Biochemistry, and Molecular Genetics
Rutgers New Jersey Medical School
Dr. Yang joined Rutgers New Jersey Medical School in 2019 as an Assistant Professor and Chancellor Scholar in the Ruy V. Lourenço Center for Emerging and Re-Emerging Pathogens and Department of Microbiology, Biochemistry, and Molecular Genetics. He leads a highly diverse research team focused on developing innovative therapies for chronic and infectious diseases using systems biology and synthetic biology approaches.
Dr. Yang received a B.S. in Biomedical Engineering from the Johns Hopkins University in 2005, with a second major in Electrical Engineering. He subsequently received his Ph.D. in Biomedical Engineering from the University of Virginia in 2012, working in the laboratory of Dr. Jeffrey Saucerman to study cellular mechanisms governing GPCR signaling dynamics in cardiac myocytes. Dr. Yang completed his postdoctoral training at the Massachusetts Institute of Technology and Broad Institute of MIT and Harvard, working in the laboratory of Dr. James Collins to study metabolic mechanisms of bactericidal antibiotic lethality. In addition to his academic training, Dr. Yang has also worked as a fellow with AstraZeneca Pharmaceuticals and Flagship Pioneering.
Dr. Yang’s multidisciplinary research program integrates the use of high-throughput, quantitative experimentation with network modeling and machine learning to accelerate the discovery of causal biological mechanisms. He has developed interpretable machine learning approaches for studying cellular phenotypes by applying biological network models as curated priors for informing machine learning models. The Yang Lab at Rutgers New Jersey Medical School is now extending these approaches to tackle the global health challenges posed by antimicrobial resistance, tuberculosis, and cardiovascular disease. With support from the Agilent Early Career Professor Award, Dr. Yang’s team is reverse engineering the biological circuitry of human macrophages to enable the development of immunoengineered synthetic macrophages that can be used to treat infections, autoimmunity, and cancer.
Dr. Yang additionally serves as Co-Chair of the Rutgers COVID Research Alliance within the Rutgers Center for COVID-19 Response and Pandemic Preparedness. He is the recipient of a NIH K99/R00 Pathway to Independence Award and University of Virginia Jill E. Hungerford Biomedical Sciences Prize.
Purpose of Award
- Promote and encourage excellent research enabling measurements of importance to Agilent Technologies and the world
- Establish strong collaborative relationships between Agilent researchers and leading professors early in their career
- Build the prominence of Agilent as a sponsor of university research
- Significant original research contributions enabling measurements of importance to Agilent Technologies and the world
- Outstanding potential for future research
- Alignment with specified award focus
- Professor completed Ph.D. (residency in case of M.D.'s or M.D. Ph.D's) not earlier than January 2011. See FAQ
- An unrestricted research award of $100,000 to be distributed in 2 years to the university in the professor's name
- Option to use all or part of the award to obtain Agilent products at a 50% discount
- Option to accelerate payments to facilitate procurement of equipment with list price over $100,000
- Engraved plaque commemorating award
- Recognition on Agilent's website
2022 AECPA Information
- Award focus, instructions and deadlines will be posted in October 2021.